Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation
Status:
Withdrawn
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine whether or not continuous combined oral contraceptive
pills (COCP's) decrease the risk of recurrent endometrioma formation. The investigators'
hypothesis is that patients who have endometriomas surgically removed and then are started on
COCP's will have a decreased incidence of recurrent endometrioma formation. The
investigators' research protocol is designed to show a statistically significant decreased
incidence of endometrioma formation in the hopes that physicians will use COCP's in patients
they have removed an endometrioma in who do not desire immediate fertility. Long term, the
investigators hope to establish a standard of care that COCP's be used postoperatively in
appropriate candidates to decrease the chance of recurrent endometrioma formation.